Biocompatibility and biostability of metallic endovascular implants: state of the art and perspectives.
More than a million metallic endovascular devices are implanted each year, but the quest for the perfect material continues. The importance of interfacial properties in the overall biocompatibility of metals and alloys has been recognized for a long time. In particular, these properties modulate the hemocompatibility of devices in contact with blood and, in turn, strongly influence implantation outcomes. In this article, the relative properties of metallic materials commonly used in endovascular applications are reviewed. Particular emphasis is given to the corrosion behavior of metallic endovascular materials and the specific surface treatments used in the production processes. Issues relative to corrosion assays will also be reviewed in terms of their relevance to in vivo applications. The potential adverse effects of degradation products with respect to endovascular applications will be described. Finally, this review addresses future perspectives of metallic devices in endovascular procedures in view of the recent promises of antiproliferative strategies that are likely to profoundly modify current procedures.
Thierry
Benjamin
B
Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada.
Tabrizian
Maryam
M
D000818:Animals; D001672:Biocompatible Materials; D001673:Biodegradation, Environmental; D001807:Blood Vessel Prosthesis; D003343:Corrosion; D006801:Humans; D008670:Metals; D011475:Prosthesis Failure; D012008:Recurrence; D013499:Surface Properties
D001672:Biocompatible Materials; D008670:Metals